Evaluating the Antifibrotic Potential of Naringenin, Asiatic Acid, and Icariin Using Murine and Human Precision-cut Liver Slices

Overview

Journal Physiol Rep

Specialty Physiology

Date 2024 Nov 6

PMID 39501714

Authors

Ke Luo

Yana Geng

Dorenda Oosterhuis

Vincent E de Meijer

Peter Olinga

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis is an exaggerated wound healing response defined by the excessive accumulation of extracellular matrix. This study investigated the antifibrotic potential of naringenin (NRG), asiatic acid (AA), and icariin (ICA) using murine and human precision-cut liver slices (PCLS). These natural products have shown promise in animal models, but human data are lacking. In this study, PCLS prepared from male mouse liver tissue (mPCLS), healthy human liver tissue (hhPCLS), and cirrhotic human liver tissue (chPCLS) were cultured for 48 h with varying concentrations of the three compounds. Our findings indicate that NRG reduced collagen type 1 (COL1A1) expression in a concentration-dependent manner in both mPCLS and chPCLS, decreased fibrosis-related gene expression, and significantly lowered pro-collagen type 1 (PCOL1A1) levels in the culture medium by 54 ± 21% (mPCLS) and 78 ± 35% (chPCLS). Furthermore, NRG effectively inhibited IL-1β and TNF-α in mPCLS and IL-1β in chPCLS on both gene and protein levels. AA specifically reduced COL1A1 and PCOL1A1 in chPCLS, while ICA selectively downregulated Col1a1 and Acta2 gene expression in mPCLS. This study suggests NRG's potential as an effective antifibrotic agent, warranting further investigation into its mechanisms and therapeutic applications in liver fibrosis.

Citing Articles

Evaluating the antifibrotic potential of naringenin, asiatic acid, and icariin using murine and human precision-cut liver slices.

Luo K, Geng Y, Oosterhuis D, de Meijer V, Olinga P Physiol Rep. 2024; 12(21):e16136.

PMID: 39501714 PMC: 11538472. DOI: 10.14814/phy2.16136.

References

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S . The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011; 1813(5):878-88. DOI: 10.1016/j.bbamcr.2011.01.034. View

Roehlen N, Crouchet E, Baumert T . Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells. 2020; 9(4). PMC: 7226751. DOI: 10.3390/cells9040875. View

Nagamoto T, Eguchi G, Beebe D . Alpha-smooth muscle actin expression in cultured lens epithelial cells. Invest Ophthalmol Vis Sci. 2001; 41(5):1122-9. View

Naseem S, Hussain T, Manzoor S . Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies. Cytokine Growth Factor Rev. 2018; 39:36-45. DOI: 10.1016/j.cytogfr.2018.01.002. View

Ye L, Yu Y, Zhao Y . Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol. 2019; 35(3):482-491. DOI: 10.1111/jgh.14875. View

de Graaf I, Olinga P, de Jager M, Merema M, de Kanter R, van de Kerkhof E . Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc. 2010; 5(9):1540-51. DOI: 10.1038/nprot.2010.111. View

Yun K, Kim J, Kim J, Lee K, Jeong S, Park H . Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int Immunopharmacol. 2008; 8(3):431-41. DOI: 10.1016/j.intimp.2007.11.003. View

Ghosh A, Vaughan D . PAI-1 in tissue fibrosis. J Cell Physiol. 2011; 227(2):493-507. PMC: 3204398. DOI: 10.1002/jcp.22783. View

Seki E, Schwabe R . Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2014; 61(3):1066-79. PMC: 4306641. DOI: 10.1002/hep.27332. View

10.

Lee M, Kim S, Yang H, Lim D, Ryu J, Lee E . Asiatic acid derivatives protect primary cultures of rat hepatocytes against carbon tetrachloride-induced injury via the cellular antioxidant system. Nat Prod Commun. 2009; 4(6):765-8. View

11.

Schuppan D, Afdhal N . Liver cirrhosis. Lancet. 2008; 371(9615):838-51. PMC: 2271178. DOI: 10.1016/S0140-6736(08)60383-9. View

12.

Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R . Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. Eur J Pharmacol. 2014; 746:96-105. DOI: 10.1016/j.ejphar.2014.10.027. View

13.

Xiong D, Deng Y, Huang B, Yin C, Liu B, Shi J . Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats. Int Immunopharmacol. 2015; 30:157-162. DOI: 10.1016/j.intimp.2015.11.035. View

14.

Lipson K, Wong C, Teng Y, Spong S . CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012; 5(Suppl 1):S24. PMC: 3368796. DOI: 10.1186/1755-1536-5-S1-S24. View

15.

Hua Y, Zeng Y, Xu J, Le Xu X . Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoemice: role of SIRT1. Phytomedicine. 2020; 81:153412. DOI: 10.1016/j.phymed.2020.153412. View

16.

Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T . Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990; 63(6):1149-57. DOI: 10.1016/0092-8674(90)90411-7. View

17.

Olinga P, Schuppan D . Precision-cut liver slices: a tool to model the liver ex vivo. J Hepatol. 2013; 58(6):1252-3. DOI: 10.1016/j.jhep.2013.01.009. View

18.

Rockey D, Bell P, Hill J . Fibrosis--a common pathway to organ injury and failure. N Engl J Med. 2015; 372(12):1138-49. DOI: 10.1056/NEJMra1300575. View

19.

Somboonwong J, Kankaisre M, Tantisira B, Tantisira M . Wound healing activities of different extracts of Centella asiatica in incision and burn wound models: an experimental animal study. BMC Complement Altern Med. 2012; 12:103. PMC: 3492213. DOI: 10.1186/1472-6882-12-103. View

20.

Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H . Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010; 139(1):323-34.e7. PMC: 4631262. DOI: 10.1053/j.gastro.2010.03.052. View